Patent Ductus Arteriosus in Infancy

Patent ductus arteriosus in infancy.

In a report on 1,000 autopsies performed on patients dying of congenital heart disease, Abbott (1937) found that the principal lesion was a patent ductus arteriosus in 282 patients; 20% of these were infant deaths. Subsequently numerous reports have stressed that while this abnormality can prove fatal during the first year of life, surgery in skilled hands offers an effective remedy at this age...

Patent ductus arteriosus in infancy.

Intravenous Paracetamol and Patent Ductus Arteriosus Closure

Background: Standard medical treatments for patent ductus arteriosus (PDA) closure are, including indomethacin/ibuprofen and surgical ligation. Nowadays, a new strategy to close PDA is the use of paracetamol. The present study aimed to describe the use of intravenous (IV) paracetamol for PDA closure in neonates who present a contraindication to ibuprofen or ibuprofen failure with no possibility...

Patent ductus arteriosus in a lamb: A case report

Patent ductus arteriosus (PDA) is a persistent patency of a vessel normally present in the fetus that connects the pulmonary arterial system to the aorta. The ductus arteriosus fails to close at birth when breathing commences and placental blood circulation is removed. Closure of the ductus arteriosus arises in response to decline pulmonary vascular resistance and increased systemic vascular re...

The diagnosis of patent ductus arteriosus in infancy.